Hong Kong-listed innovative pharmaceutical stocks continue to decline, with many stocks such as Zhaoyan Pharmaceuticals falling by more than 3%.

Hong Kong-listed innovative pharmaceutical stocks continue to decline, with Innovent Biologics falling more than 4%, and Stone Pharmaceutical Group, Junshi Biosciences, Lee's Pharmaceutical, and Zhao Yan New Drug all dropping more than 3%.